MAPK3 risk_factor_for schizophrenia
Evidence from:
primary |
all sources
Evidence (1 sources)
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
(2022)
PMID:35396580
cited
modulation of chemical transmission (MAPK3, DCC, CLCN3, DLGAP2). The diversity of synaptic proteins ... suggests multiple functional interactions of schizophrenia risk.
confidence: 0.94